Medical management of this side effect is complicated in rheumatology patients.
TNF Blockade for SLE
Reckless approach versus missed opportunity?
Mitigate Risk and Increase Success of Lupus Clinical Trials
Design strategies from a Lupus Research Institute conference
Drug Updates
Information on New Approvals and Medication Safety
Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease
A perspective on B cell–targeted therapies in autoimmune disease
Systemic Lupus Erythematosus
Systemic lupus erythematosus, often called SLE or lupus, is a chronic inflammatory disease that can affect the skin, joints, kidneys, lungs, nervous system, and other organs of the body. It is sometimes labeled the “great imitator” because its wide variety of symptoms can often be confused with other disorders. Usually, patients with SLE experience skin rashes and arthritis as well as fatigue and fever, and the disease can be fatal. However, improvements in therapy have significantly increased these patients’ quality of life and their life expectancy.
The Brain in Lupus
The Mary Kirkland Center lupus conference offers insight into cognitive aspects of SLE
Safety First
Phase 1 clinical trials present recruitment challenges for rheumatology researchers
Opportunities Abound at Annual Meeting
The 2008 ACR/ARHP Annual Scientific Meeting will offer multiple opportunities for attendees to increase their knowledge of rheumatic diseases. New educational programs and returning favorites will give attendees multiple chances to enhance their education and make good use of their time at the meeting.
A Better Family Plan
How to minimize the risks of pregnancy for women with SLE